CH251533A - Process for the manufacture of a cosmetic product. - Google Patents
Process for the manufacture of a cosmetic product.Info
- Publication number
- CH251533A CH251533A CH251533DA CH251533A CH 251533 A CH251533 A CH 251533A CH 251533D A CH251533D A CH 251533DA CH 251533 A CH251533 A CH 251533A
- Authority
- CH
- Switzerland
- Prior art keywords
- double bonds
- conjugated
- molecule
- carboxylic acids
- diluent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 14
- 239000002537 cosmetic Substances 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 230000008569 process Effects 0.000 title claims description 5
- 150000001735 carboxylic acids Chemical class 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000003883 ointment base Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims 5
- 230000001419 dependent effect Effects 0.000 claims 2
- 150000007513 acids Chemical class 0.000 claims 1
- 239000012749 thinning agent Substances 0.000 claims 1
- 239000000758 substrate Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 6
- 239000000344 soap Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 239000003599 detergent Substances 0.000 description 3
- -1 fatty acid salts Chemical class 0.000 description 3
- JBYXPOFIGCOSSB-UHFFFAOYSA-N octadeca-9,11-dienoic acid Chemical compound CCCCCCC=CC=CCCCCCCCC(O)=O JBYXPOFIGCOSSB-UHFFFAOYSA-N 0.000 description 3
- JBYXPOFIGCOSSB-UQGDGPGGSA-N rumenic acid Chemical compound CCCCCC\C=C/C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-UQGDGPGGSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- DTRGDWOPRCXRET-UHFFFAOYSA-N (9Z,11E,13E)-4-Oxo-9,11,13-octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCC(=O)CCC(O)=O DTRGDWOPRCXRET-UHFFFAOYSA-N 0.000 description 1
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 description 1
- DTRGDWOPRCXRET-SUTYWZMXSA-N (9e,11e,13e)-4-oxooctadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCC(=O)CCC(O)=O DTRGDWOPRCXRET-SUTYWZMXSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IJTNSXPMYKJZPR-UHFFFAOYSA-N parinaric acid Chemical class CCC=CC=CC=CC=CCCCCCCCC(O)=O IJTNSXPMYKJZPR-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Verfahren zur Herstellung eines kosmetischen Produktes.
Gegenstand der vorliegenden Erfindung ist ein Verfahren zur Herstellung eines kos- metischen Produktes, das dadurch gekenn- zeichnet is. t, dass man zur Bildung des Anions ungesättigter, mindestens zwei konjugierte C, C-Doppelbindungen im Molek l enthaltender Carbonsäuren befähigte Verbindungen mit einem andern,, jedodh biologisch unwirksa. men Stoff bis au. einen Gehalt von h¯chstens 10 000 Shepherd-Linn-Einheiten im g verdünnt.
Es wurde nämlich gefunden, dass zur Bildung des Ions ungesättigter,mindestenszwei konjugierte C, C-Doppelbindungen enthaltender Carbonsäuren befähigte Verbindungen, wie e z. B. bestimmte Fraktionen ungesättigter, zwei oder mehr konjugierte Doppelbin dungen im Molekül enthaltende Carbonsäuren und ihre stereoisomeren Formen und/oder deren, dissoziierfÏhige Derivate sich zur Herstellung von kosmetischen Produkten hervorragend eignen und eine gegenüber den 9, 10-LinolsÏuren (a, ¯, y) in der Potenz erhöhte Vitamin-F-Wirksamkeit besitzen, wenn sie mit einem andern, jedoch biologisch unwirksamen Stoff, wie. z.
B. festen @ oder fl s- sigen L¯sungsmitteln, insbesondere Salb@n- grundstoffen,Wasser usw., verdünnt werden.
Dies ist berraschend, da die unverdünnten, mindestens zwei konjugierte C, C-Doppelbin- dungen enthaltenden Stoffe keine bei Kosmetika erw nschte Wirkung ergeben, sondern zu auffallenden Toxizitätserscheinungen führten.
Es s hat sich gezeigt, dass nach dem erfindungsgemässen Verfahren Produkte, wie z. B.
Hautsalben, -¯le, -cremen und -puder, Ge sichtswasser, Haa/rwasser, Waschmittel, wie Toiletten- und Rasierseifen, erhalten werden können, bei welchen einer hautsehädigenden Wirkung üblicher Bestandteile derartiger Produkte entgegengewirkt ist, so z. B. bei kosmetischen Zwecken dienenden Waschmit- teln aus auf fettsauren Salzen basierten Normalseièn, synthetischen Seifen, wie Fett- alkoholsulfonaten, t rkischrot¯lartigen Seifen, Kondensationsprodukten von Fettsäuren un, EiweissundganzseifenloseWaschmittel, z. B. biologisch und/oder durch L¯sungsmittel oder Alkalien wirksame, und deren Gemischen.
Für das vorliegende Verfahren haben sich z. B. die im folgenden genannten Stoffe als geeignet erwiesen : 1. die zweifach konjugiert ungesättigte 9, 11-OctadekadiensÏure (trans-cis-OctadekadiensÏure)
CH3 À (CH2)5 À (CH=CH)2 À (CH2)7-COOH, 2. die dreifach konjugiert ungesättigte ElaeostearinsÏure
CH3 À (CH2)3 À (CH=CH)3 À (CH2)7-COOH, 3. die dreifaoh konjugiert ungesättigte Holzfettsäure des Orticicadls, die Ijieansäure
CH3 À (CH2)3 À (CH=CH)3 À (CH2)4 À CO À (CH2)2-COOH, 4. die vierfach konjugiert ungesättigte Parinarsäure des Faktors von Parinarium laurinum, deren Eonstitution erst kürzlich von H.
P. Kaufmann und J. Balles aufgeklärt werden konnte (vergleiche"Fette und Seifen", 45, 302/1938) :
CH3 CH2 À (CH = CH)4 À (CH2)7-COOH.
Ausserdem kommen in Betracht alle eyn- thetisch hergestellten Polyenfettsäuren mit zwei und mehr konjugierten Doppelbindungen, die z. B. mit der von R. kuhn, Heidelberg, angegebenen Methode gewonnen werden können und worüber J. Baltes in der Zeitschrift äFette und Seifen", 45, 196 (1938) zusammenfassend berichtet hat.
Ferner k¯nnen auch nat rliche und/oder künstlicheGemische verwendet werden, die Carbonsäuren und/oder dtssoziierfähigeDeri- vate solcher enthalten, welche zwei oder mehr konjugierte Doppelbindungen im Molekül aufweisen, wie z. B.
1. die natürlichen Fette in der Art des Eolz ols, Oiticicaols, 2. aus natüdichen O'len durch chemische
Modifikation erhaltene Produkte, z. B. dehydratisiertes Rizinusöl, dehydrierte
Fette aller Art, und 3. natürliche, physikalisch-chemisch modifi- zierte Fette.
Unter dissoziierfÏhigen Derivaten sind z. B. wässerige L¯sungen der Salze (Seifen) der genannten CarbonsÏuren mit dem Konstitutionsmerkmal der mindestens zwei konjugierten Doppelbindungen zu verstehen.
Der Erfindung liegt die Erkenntnis zu Grunde, dass die in Frage stehenden Carbonsauren usw. nicht in konzentrierter, reiner Form, sondern erst mit ändern Stoffen ver- dünnt, haltbare, hochwirks'ame Präparate für kosmetisohe Zwecke ergeben, und daB durch die Verdünnung der hochungesättigten Carbonsäuren und deren dissoziierfÏhigen@ Deri- vaten, die zwei oder mehr konjugierte Dop- pelbindungen enthalten, nicht nur erst der biologische Schutzeffekt auf der Haut von Mensch und Tier zustande kommt, sondern auch gleichzeitig die Vitamin-F-wirksame Substanz vor Autoxydation, Polymerisation und damit Inaktivierung geschützt wird.
Unter den genannten, in Verdünnung Vitamin-F-wirksamen Stoffen befinden sich jedoch auch solche, die von Natur aus auch bei bereits geringfügiger Verdünnung meh rere für die praktische Anwendung in der Kosmetik angenehme Eigenschaften haben.
So hat z. B. die 9, 11-OctadekadiensÏure (ge genüber der durch ihre Vitaminwirkung be kannten 9, 10-Linolsäure) den Vorteil, eine helle, wasserklare Fl ssigkeit, die bis-7' fliissig bleibt und weitgehendst licht-, luft- un, d alterungsbestÏndig ist, zu sein.
Beispiele: Hautsalben : a) 9, 11-OctadekadiensÏure 1,0 Vaselinum album 5X0, 0 Eucerin,anhyd.adK)0, 0 (etwa 25'00 Shepherd-Linn
Einheiten pro g Substrat). b) 9, 11-OctadekadiensÏure 0, 4 Adbps benzoatus 100, 0 (etwa 1000 Shepherd-Linn
Einheiten pro g Substrat). c) 9, 11-OctadekadiensÏure 0, 25
Oleum campheratum 2, 0
Lanolin ad 30, 0 (etwa 1000 Shepherd-Linn-
Einheiten pro g Substrat).
Puder :
9, 11-OctadekadiensÏure 1, 0
Lanolin 1, 0
Acid, Boric. 2, 5
Zinc. Oxyd. 20, 0
Bolus alba (weisse Tonerde) 100, 0 (etwa 2500 Shepherd-Linn
Einheiten pro g Substrat).
Hautfunktions6l :
ElaeostearinsÏure 0, 2
Oleum Vaselini 50, 0 (etwa 1000 Shepherd-Linn-
Einheiten pro g Substrat).
Hautcremen (Gold cream) :
Man emulgiert :
9, 11-Octadekadiensäure 0, 4 Alcoh. cetyl 20, 0
Paraff. liqu. 20, 0
Vaselinum album 59, 6
Wasser (37, 5%) 60, 0 (etwa 2500 Shepherd-Linn-Einheiten pro g
Substrat auf Trockensubstanz berechnet).
Haarwasser :
Licansäure 0, 1
Spiritus 60, 0
Spirit, odorat 5, 0
Glycerin 5, 0
Acid. salicyl 2, 0
Aqua dest. ad 100, 0 (etwa 250 Shepherd-Isinn-
Einheiten pro g Substrat).
Gesichtswasser (zugl. Desinfe7ctionsmittel) :
9, 11-Octadekadiensäure 0, 2
Triäthanolamin 0, 5
Glycerin 4, 0 Spiritus 33, 0
Aqua dest. 62, 0
Parfum 0, 8 (etwa 500 Shepherd-Iminn-
Einheiten pro g Substrat).
Process for the manufacture of a cosmetic product.
The present invention relates to a method for producing a cosmetic product which is characterized by it. t that one can form the anion of unsaturated, at least two conjugated C, C double bonds in the molecule containing carboxylic acids with another, but biologically ineffective compounds. men fabric to au. diluted to a content of not more than 10,000 Shepherd-Linn units per gram.
This is because it has been found that compounds capable of forming the ion of unsaturated carboxylic acids containing at least two conjugated C, C double bonds, such as e. B. certain fractions of unsaturated, two or more conjugated double bonds in the molecule containing carboxylic acids and their stereoisomeric forms and / or their, dissociable derivatives are ideal for the production of cosmetic products and compared to the 9, 10-linoleic acids (a, ¯, y ) have increased potency vitamin F effectiveness when combined with another, but biologically inactive substance, such as. z.
B. solid or liquid solvents, especially ointment base materials, water, etc., can be diluted.
This is surprising, since the undiluted substances containing at least two conjugated C, C double bonds do not have the desired effect on cosmetics, but rather lead to striking symptoms of toxicity.
It s has been shown that according to the inventive method products such. B.
Skin ointments, oils, creams and powders, Ge facial water, hair water, detergents, such as toilet and shaving soaps, can be obtained in which a skin-damaging effect of common components of such products is counteracted, e.g. For example, detergents for cosmetic purposes made from normal iron based on fatty acid salts, synthetic soaps such as fatty alcohol sulfonates, turkish roll-like soaps, condensation products of fatty acids, detergents without protein and soaps, e.g. B. biologically and / or by solvents or alkalis effective, and mixtures thereof.
For the present process z. B. the substances mentioned below have proven to be suitable: 1. the doubly conjugated unsaturated 9, 11-Octadienure (trans-cis-OctadekadiensÏure)
CH3 À (CH2) 5 À (CH = CH) 2 À (CH2) 7-COOH, 2. the tri-conjugated unsaturated eleostearic acid
CH3 À (CH2) 3 À (CH = CH) 3 À (CH2) 7-COOH, 3. the threefold conjugated unsaturated wood fatty acid of orticicadl, the Ijiean acid
CH3 À (CH2) 3 À (CH = CH) 3 À (CH2) 4 À CO À (CH2) 2-COOH, 4. the fourfold conjugated unsaturated parinaric acid of the factor of Parinarium laurinum, the constitution of which was recently published by H.
P. Kaufmann and J. Balles could be enlightened (compare "Fette und Seifen", 45, 302/1938):
CH3 CH2 À (CH = CH) 4 À (CH2) 7-COOH.
In addition, all synthetically produced polyene fatty acids with two or more conjugated double bonds, which z. B. can be obtained with the method specified by R. kuhn, Heidelberg, and what J. Baltes has reported in summary in the journal "Fat and Seifen", 45, 196 (1938).
Furthermore, natural and / or artificial mixtures can also be used which contain carboxylic acids and / or derivatives capable of being associated with those which have two or more conjugated double bonds in the molecule, such as B.
1. Natural fats in the form of Eolz oil, Oiticicaols, 2. From natural oils by chemical means
Modification obtained products, e.g. B. dehydrated castor oil, dehydrated
Fats of all kinds, and 3. natural, physico-chemical modified fats.
Derivatives capable of dissociation are e.g. B. aqueous solutions of the salts (soaps) of the carboxylic acids mentioned with the constitutional feature of at least two conjugated double bonds.
The invention is based on the knowledge that the carboxylic acids etc. in question do not result in a concentrated, pure form but only diluted with other substances, producing durable, highly effective preparations for cosmetic purposes, and that by diluting the highly unsaturated ones Carboxylic acids and their dissociable @ derivatives, which contain two or more conjugated double bonds, not only does the biological protective effect on the skin of humans and animals come about, but also at the same time the vitamin F-active substance against autoxidation, polymerization and so that inactivation is protected.
However, among the substances mentioned, which are effective when diluted with vitamin F, there are also those which by nature have several pleasant properties for practical use in cosmetics, even if they are even slightly diluted.
So has z. For example, 9, 11-octadecadienoic acid (compared to 9, 10-linoleic acid, which is known for its vitamin action) has the advantage of being a light, water-clear liquid that remains liquid up to -7 'and is largely light, air and is resistant to aging.
Examples: Skin ointments: a) 9, 11-Octadecadienic acid 1.0 Vaselinum album 5X0, 0 Eucerin, anhyd.adK) 0, 0 (about 25,000 Shepherd-Linn
Units per g substrate). b) 9, 11-octadecadienic acid 0.4 Adbps benzoatus 100, 0 (about 1000 Shepherd-Linn
Units per g substrate). c) 9, 11-octadecadienic acid 0.25
Oleum campheratum 2, 0
Lanolin ad 30.0 (about 1000 Shepherd-Linn
Units per g substrate).
Powder:
9, 11-octadecadic acid 1, 0
Lanolin 1, 0
Acid, Boric. 2, 5
Zinc. Oxide. 20, 0
Bolus alba (white clay) 100.0 (about 2500 Shepherd-Linn
Units per g substrate).
Skin function:
Eleostearic acid 0, 2
Oleum Vaselini 50.0 (about 1000 Shepherd-Linn
Units per g substrate).
Skin creams (gold cream):
One emulsifies:
9, 11-octadecadienoic acid 0.4 Alcoh. cetyl 20.0
Paraff. liqu. 20, 0
Vaselinum album 59, 6
Water (37.5%) 60.0 (about 2500 Shepherd-Linn units per g
Substrate calculated on dry matter).
Hair tonic:
Licanic acid 0.1
Spirit 60, 0
Spirit, odorat 5, 0
Glycerin 5, 0
Acid. salicylic 2, 0
Aqua dest. ad 100.0 (about 250 Shepherd-Isinn-
Units per g substrate).
Facial tonic (including disinfectant):
9, 11-octadecadienoic acid 0, 2
Triethanolamine 0.5
Glycerin 4, 0 Spirit 33, 0
Aqua dest. 62, 0
Perfume 0.8 (about 500 Shepherd Iminn
Units per g substrate).
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL251533X | 1938-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH251533A true CH251533A (en) | 1947-10-31 |
Family
ID=19781128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH251533D CH251533A (en) | 1938-05-27 | 1939-05-26 | Process for the manufacture of a cosmetic product. |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH251533A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE900122C (en) * | 1951-08-24 | 1953-12-21 | Karl Rothemann | Active washing agent that is gentle on fibers and fabrics |
-
1939
- 1939-05-26 CH CH251533D patent/CH251533A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE900122C (en) * | 1951-08-24 | 1953-12-21 | Karl Rothemann | Active washing agent that is gentle on fibers and fabrics |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69930020T2 (en) | Composition which causes a cooling effect | |
DE2405004C3 (en) | Deodorants | |
DE1917393A1 (en) | Perfumed and flavored products | |
DE69103648T2 (en) | Lactic acid acylates, their salts, their manufacturing process and compositions containing them. | |
DE2458562A1 (en) | CONSUMER PRODUCT WITH PHYSIOLOGICAL COOLING EFFECT | |
CH251533A (en) | Process for the manufacture of a cosmetic product. | |
CH667806A5 (en) | COSMETIC AGENTS WITH SKIN SOOTHING AND SKIN REGENERATING EFFECT AND A METHOD FOR THE PRODUCTION THEREOF. | |
DE2623250A1 (en) | MILK SHAMPOO | |
DE2421618A1 (en) | SKIN CARE AND SKIN PROTECTION PRODUCTS WITH A CONTENT OF SKIN MOISTURIZERS | |
EP0107846B1 (en) | Composition for the care or treatment of the human skin | |
DE2129212A1 (en) | Cosmetic cosmetics | |
CH302734A (en) | Clear, highly concentrated solution of synthetic detergent substances, especially head washes and head care products. | |
DE69402409T2 (en) | VISMIA EXTRACT CONTAINING COSMETIC OR PHARMACEUTICAL PREPARATION, ESPECIALLY DERMATOLOGICAL. | |
DE3590272T (en) | Vegetable oil extracts as emollients in skin and hair care products | |
DE891323C (en) | Cosmetic product | |
CH399655A (en) | Skin care products | |
DE1568320B2 (en) | Cosmetic active ingredient and cosmetic agent with water-retaining properties | |
AT132834B (en) | Process for the production of solid, long-lasting mixtures of plant preparations with compounds containing active oxygen. | |
DE872827C (en) | Skin care products and processes for their manufacture | |
DE1617542A1 (en) | Process for the preparation of stable solutions of lecithin, especially soybean lecithin, in aqueous, sugary alcohol | |
DE691534C (en) | Process for the preparation of disinfecting aqueous solutions of phenol, its homologues and derivatives | |
DE906982C (en) | Process for the production of durable, highly effective vitamin F preparations | |
DE614081C (en) | Process for the production of preparations containing active oxygen | |
DE657116C (en) | Antiseptic detergents | |
DE2757937A1 (en) | Skin-care cosmetics - contg. calf's blood haemodialysate |